Controlled Release Bilayer Floating Effervescent and Noneffervescent Tablets Containing Levofloxacin...
Controlled Release Bilayer Floating Effervescent and Noneffervescent Tablets Containing Levofloxacin and Famotidine
About this item
Full title
Author / Creator
Publisher
New York: Hindawi
Journal title
Language
English
Formats
Publication information
Publisher
New York: Hindawi
Subjects
More information
Scope and Contents
Contents
The present study is aimed at designing bilayer-floating tablets to improve the drug concentration in the stomach for enhanced therapeutic efficacy. The tablets are comprised of an upper layer of levofloxacin (466.5 mg) and a lower layer of famotidine (133.5 mg). Five formulations (F1-F5) were developed by using hydroxypropyl methylcellulose grades...
Alternative Titles
Full title
Controlled Release Bilayer Floating Effervescent and Noneffervescent Tablets Containing Levofloxacin and Famotidine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_098fd5653be542b880cf7cf29c3593f6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_098fd5653be542b880cf7cf29c3593f6
Other Identifiers
ISSN
1687-9422
E-ISSN
1687-9430
DOI
10.1155/2024/1243321
